Record

RefNoEC/1982/20
Previous numbersCert XXI, 64
LevelItem
TitleLachmann, Peter Julius: certificate of election to the Royal Society
Date1978
DescriptionCitation typed
CitationDistinguished for his contributions to immunochemistry and immunopathology. He made early and important studies on anti-nuclear antibodies. He purified and characterized conglutinin and distinguished it from immuno-conglutinin. He is especially distinguished for his contributions to the study of complement. He was the first to demonstrate bound complement in tissue sections. He discovered C3b Inactivator and the C3b feedback cycle, and he elucidated (with Thompson) the mechanism of reactive lysis. He is a leading investigator on complement deficiency and polymorphisms and in the use of haemolytic diffusion plates in the assay of complement components. He was also one of the first to publish evidence for antigen-specific T cell factors.
AccessStatusClosed
Fellows associated with this archive
CodePersonNameDates
NA4481Lachmann; Sir; Peter Julius (1931 - 2020)1931 - 2020
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView